Jason D. Smith

Insider Reports History

Location
C/O Urogen Pharma Ltd., 400 Alexander Park Drive, Princeton, NJ
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason D. Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. General Counsel Ordinary Shares 43.3K $828K $19.11 Sep 8, 2025 Direct
UroGen Pharma Ltd. General Counsel Restricted Stock Units 3.33K Sep 7, 2025 Direct

Insider Reports Filed by Jason D. Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Sep 7, 2025 3 -$29K 4 Sep 9, 2025 General Counsel
URGN UroGen Pharma Ltd. Jul 28, 2025 2 -$144K 4 Jul 30, 2025 General Counsel
URGN UroGen Pharma Ltd. Jan 31, 2025 10 -$82.2K 4 Feb 4, 2025 General Counsel
URGN UroGen Pharma Ltd. Sep 9, 2024 3 -$19.9K 4 Sep 12, 2024 General Counsel
URGN UroGen Pharma Ltd. Jan 31, 2024 3 -$78.8K 4/A Feb 5, 2024 General Counsel
URGN UroGen Pharma Ltd. Jan 31, 2024 10 -$78.6K 4 Feb 2, 2024 General Counsel
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 General Counsel
URGN UroGen Pharma Ltd. Aug 31, 2023 3 -$68.4K 4 Sep 5, 2023 General Counsel
URGN UroGen Pharma Ltd. Jan 31, 2023 8 -$16.6K 4 Feb 2, 2023 General Counsel
URGN UroGen Pharma Ltd. Aug 31, 2022 3 -$26K 4 Sep 2, 2022 General Counsel
URGN UroGen Pharma Ltd. Jan 31, 2022 5 -$3.14K 4 Feb 2, 2022 General Counsel
URGN UroGen Pharma Ltd. Nov 30, 2021 3 -$45.8K 4 Dec 2, 2021 General Counsel
URGN UroGen Pharma Ltd. Jun 5, 2021 1 $0 4 Jun 8, 2021 General Counsel
URGN UroGen Pharma Ltd. May 17, 2021 1 $39.3K 4 May 18, 2021 General Counsel